This situation does
not come up very often. Two examples would be Pneumocystis jovenii
and Stenotrophomonas maltophilia. There is a scarcity of data to
guide clinicians in dosing the drug in critically ill patients. This
review (free full text) presents a summary of what information
we do have, and provides dosing recommendations.
No comments:
Post a Comment